Has the Abbott Laboratories Sell-Off Finally Created an Entry Point? [Yahoo! Finance]
Abbott Laboratories (ABT)
Last abbott laboratories earnings: 4/16 07:30 am
Check Earnings Report
US:NYSE Investor Relations:
abbott.com/investors.html
Company Research
Source: Yahoo! Finance
Abbott Labs is a quality franchise at a discounted price, but some investors may want to wait for two key developments to be resolved. The analyst who called NVIDIA in 2010 just named his top 10 AI stocks. Get them here FREE Whether Abbott Laboratories NYSE: ABT ) stock is at a good entry point depends on your investment horizon and tolerance for near-term uncertainty. The stock has been punished hard in 2026, and the question is whether that punishment has overshot the fundamentals. Abbott Labs is a diversified healthcare giant spanning medical devices, diagnostics, nutrition, and established pharmaceuticals. Its $168 billion market cap reflects decades of compounding, but the stock has unwound gains over the past year. A $21 billion acquisition of Exact Sciences, completed in March, added cancer diagnostics brands Cologuard and Cancerguard while introducing integration costs and EPS dilution the market is still digesting. The Bull Case: Quality at a Discount Abbott delive
Show less
Read more
Impact Snapshot
Event Time:
ABT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ABT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ABT alerts
High impacting Abbott Laboratories news events
Weekly update
A roundup of the hottest topics
ABT
News
- Abbott Stock Crash: Rebound Could Be Coming Fast [Yahoo! Finance]Yahoo! Finance
- New data at AACR 2026 demonstrate advancements in Cancerguard® Multi-Cancer Early Detection Test [Yahoo! Finance]Yahoo! Finance
- New data at AACR 2026 demonstrate advancements in Cancerguard® Multi-Cancer Early Detection Test [TheStreet.com]TheStreet.com
- New data at AACR 2026 demonstrate advancements in Cancerguard® Multi-Cancer Early Detection TestPR Newswire
- Abbott Laboratories (ABT) had its price target lowered by Royal Bank Of Canada from $135.00 to $130.00. They now have an "outperform" rating on the stock.MarketBeat
ABT
Earnings
- 4/16/26 - Beat
ABT
Sec Filings
- 4/17/26 - Form 8-K
- 4/16/26 - Form 8-K
- 4/2/26 - Form 4
- ABT's page on the SEC website